BridgeBio Pharma Enters Seven Collaborations with University Partners
Share
Rare Daily Staff
BridgeBio Pharma announced seven separate collaborations with top academic and research institutions to support early, promising research in genetically driven diseases and cancers with clear genetic drivers.
BridgeBio announced partnerships with Brown University, GlycoNet, The Lundquist Institute, Oregon Health & Science University, Roswell Park Comprehensive Cancer Center, the University of California, San Diego; and University of California, Davis.
The latest set of deals brings the total number of partnerships between BridgeBio and leading academic and research institutions to 20 to date.
Through the partnerships BridgeBio will:
Collaborate with UC San Diego on identifying research programs with strong potential for therapeutic applications that address areas of unmet need. BridgeBio will potentially sponsor research programs and support the development of identified programs toward potential clinical investigation through its licensing and affiliate development model.